Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
51,599,531
-
Total 13F shares
-
10,495,260
-
Share change
-
+7,767,767
-
Total reported value
-
$47,701,835
-
Put/Call ratio
-
11%
-
Price per share
-
$4.54
-
Number of holders
-
40
-
Value change
-
+$35,368,248
-
Number of buys
-
23
-
Number of sells
-
16
Institutional Holders of ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) as of Q1 2024
As of 31 Mar 2024,
ACHIEVE LIFE SCIENCES, INC. - Common Stock, par value $0.001 per share (ACHV) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,495,260 shares.
The largest 10 holders included
Propel Bio Management, LLC, Sofinnova Investments, Inc., VANGUARD GROUP INC, ADAR1 Capital Management, LLC, Altium Capital Management LP, Nantahala Capital Management, LLC, CVI Holdings, LLC, Alyeska Investment Group, L.P., Shay Capital LLC, and Long Focus Capital Management, LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.